Download MendeleyVaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses.
Mukhamedova, M., Wrapp, D., Shen, C.H., Gilman, M.S.A., Ruckwardt, T.J., Schramm, C.A., Ault, L., Chang, L., Derrien-Colemyn, A., Lucas, S.A.M., Ransier, A., Darko, S., Phung, E., Wang, L., Zhang, Y., Rush, S.A., Madan, B., Stewart-Jones, G.B.E., Costner, P.J., Holman, L.A., Hickman, S.P., Berkowitz, N.M., Doria-Rose, N.A., Morabito, K.M., DeKosky, B.J., Gaudinski, M.R., Chen, G.L., Crank, M.C., Misasi, J., Sullivan, N.J., Douek, D.C., Kwong, P.D., Graham, B.S., McLellan, J.S., Mascola, J.R.(2021) Immunity 54: 769-780.e6
- PubMed: 33823129
- DOI: https://doi.org/10.1016/j.immuni.2021.03.004
- Primary Citation of Related Structures:
7LUC, 7LUD, 7LUE - PubMed Abstract:
An effective vaccine for respiratory syncytial virus (RSV) is an unrealized public health goal. A single dose of the prefusion-stabilized fusion (F) glycoprotein subunit vaccine (DS-Cav1) substantially increases serum-neutralizing activity in healthy adults. We sought to determine whether DS-Cav1 vaccination induces a repertoire mirroring the pre-existing diversity from natural infection or whether antibody lineages targeting specific epitopes predominate. We evaluated RSV F-specific B cell responses before and after vaccination in six participants using complementary B cell sequencing methodologies and identified 555 clonal lineages. DS-Cav1-induced lineages recognized the prefusion conformation of F (pre-F) and were genetically diverse. Expressed antibodies recognized all six antigenic sites on the pre-F trimer. We identified 34 public clonotypes, and structural analysis of two antibodies from a predominant clonotype revealed a common mode of recognition. Thus, vaccination with DS-Cav1 generates a diverse polyclonal response targeting the antigenic sites on pre-F, supporting the development and advanced testing of pre-F-based vaccines against RSV.
Organizational Affiliation:
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Department of Biology, Johns Hopkins University, Baltimore, MD 21218, USA.
